Temple Health Chest Initiative (THCI 2.0)
Eligible age
50–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
Sponsor: Temple University
You may qualify if…
- ✓ 50 to 80 years old
- ✓ Screened for early lung cancer using low dose CT imaging
You may not qualify if…
- ✕ Under 50; over 80 years old
- ✕ No lung cancer screening
Where it's recruiting
Philadelphia
Source: ClinicalTrials.gov · NCT06933758 · last updated 2025-04-18